Advanced Medical Optics Inc (1168335) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2005

Abbott Medical Optics Inc

CIK: 1168335








Sheree Aronson

(714) 247-8290



Steve Chesterman

(714) 247-8711




Sales Increase 24% in 2005


(SANTA ANA, CA), February 14, 2006 – Advanced Medical Optics, Inc. (AMO) [NYSE: EYE], a global leader in ophthalmic surgical devices and eye care products, today announced financial results for the fourth quarter and full year of 2005.


AMO reported 2005 net sales of $920.7 million, a 24.1 percent increase over 2004. This reflected primarily the acquisition of VISX, Incorporated in May 2005 and the Pfizer ophthalmic surgical business in June 2004, as well as increased sales of its technologically advanced products, and the unfavorable impact of the company’s accelerated rationalization of non-strategic eye care and cataract products.


For 2005, AMO reported a net loss of $453.2 million, or a loss of $8.28 per share, compared to a net loss of $129.4 million, or a loss of $3.89 per share in 2004. Per-share results for 2005 were reduced by $9.73 due to the combined effect of after-tax charges of $536.9 million and the $0.43 effect of dilutive instruments. Similarly, per-share results for 2004 were reduced by $5.13 due to the combined effect of after-tax charges of $175.8 million and the $0.62 effect of dilutive instruments. The losses in both years were due primarily to charges related to acquisitions and recapitalizations, and the company’s product rationalization and business repositioning actions in 2005. The charges were partially offset in 2005 by unrealized gains on derivative instruments and tax benefits related to repatriation of foreign earnings under the American Jobs Creation Act of 2004.


“With the close of 2005, we finished our third full year as an independent company and, in this time, nearly doubled our sales and set AMO on a new and more promising course,” said Jim Mazzo, president and chief executive officer. “With leading market share positions, a comprehensive set of superior technologies and an increasingly efficient global infrastructure, the major pieces of our growth strategy are now in place. No company is more qualified or capable than AMO to provide practitioners and patients the products and support necessary to


- more -


The following information was filed by Abbott Medical Optics Inc on Tuesday, February 14, 2006 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Abbott Medical Optics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abbott Medical Optics Inc.


Assess how Abbott Medical Optics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abbott Medical Optics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2006 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1168335
Form Type: 10-K Annual Report
Accession Number: 0001104659-06-016265
Submitted to the SEC: Tue Mar 14 2006 6:05:38 AM EST
Accepted by the SEC: Tue Mar 14 2006
Period: Saturday, December 31, 2005
Industry: Surgical And Medical Instruments And Apparatus

External Resources:

Bookmark the Permalink: